Varma MV, El-Kattan AF, Feng B, Steyn SJ, Maurer TS, Scott DO, et al. Extended Clearance Classification System (ECCS) informed approach for evaluating investigational drugs as substrates of drug transporters. Clin Pharmacol Ther. 2017;102(1):33–6.

Article  PubMed  CAS  Google Scholar 

Li R, Barton HA, Varma MV. Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved. Clin Pharmacokinet. 2014;53(8):659–78.

Article  PubMed  Google Scholar 

Yin M, Balhara A, Marie S, Tournier N, Gaborik Z, Unadkat JD. Successful prediction of human hepatic concentrations of transported drugs using the proteomics-informed relative expression factor approach. Clin Pharmacol Ther. 2024;115(3):595–605.

Article  PubMed  CAS  Google Scholar 

Bosgra S, van de Steeg E, Vlaming ML, Verhoeckx KC, Huisman MT, Verwei M, et al. Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling. Eur J Pharm Sci. 2014;65:156–66.

Article  PubMed  CAS  Google Scholar 

Alluri RV, Li R, Varma MVS. Transporter-enzyme interplay and the hepatic drug clearance: what have we learned so far? Expert Opin Drug Metab Toxicol. 2020;16(5):387–401.

Article  PubMed  CAS  Google Scholar 

Li R, Barton HA, Yates PD, Ghosh A, Wolford AC, Riccardi KA, et al. A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling. J Pharmacokinet Pharmacodyn. 2014;41(3):197–209.

Article  PubMed  CAS  Google Scholar 

Jones HM, Barton HA, Lai Y, Bi YA, Kimoto E, Kempshall S, et al. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data. Drug Metab Dispos. 2012;40(5):1007–17.

Article  PubMed  CAS  Google Scholar 

Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis–Menten model: routine clinical pharmacokinetic data. J Pharmacokinet Biopharm. 1980;8(6):553–71.

Article  PubMed  CAS  Google Scholar 

Fujino H, Yamada I, Shimada S, Yoneda M, Kojima J. Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization. Xenobiotica. 2003;33(1):27–41.

Article  PubMed  CAS  Google Scholar 

Li R, Ghosh A, Maurer TS, Kimoto E, Barton HA. Physiologically based pharmacokinetic prediction of telmisartan in human. Drug Metab Dispos. 2014;42(10):1646–55.

Article  PubMed  CAS  Google Scholar 

Bi YA, Costales C, Mathialagan S, West M, Eatemadpour S, Lazzaro S, et al. Quantitative contribution of six major transporters to the hepatic uptake of drugs: “SLC-Phenotyping” using primary human hepatocytes. J Pharmacol Exp Ther. 2019;370(1):72–83.

Article  PubMed  CAS  Google Scholar 

US Food and Drug Administration Center for Drug Evaluation and Research. NDA 210910 multi-discipline review. US FDA; 2018.

Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT 2nd, et al. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol Sci. 2013;136(1):216–41.

Article  PubMed  CAS  Google Scholar 

Lindbom L, Pihlgren P, Jonsson EN. PsN-Toolkit—a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Progr Biomed. 2005;79(3):241–57.

Article  Google Scholar 

Riccardi KA, Tess DA, Lin J, Patel R, Ryu S, Atkinson K, et al. A novel unified approach to predict human hepatic clearance for both enzyme- and transporter-mediated mechanisms using suspended human hepatocytes. Drug Metab Dispos. 2019;47(5):484–92.

Article  PubMed  CAS  Google Scholar 

Mathew S, Tess D, Burchett W, Chang G, Woody N, Keefer C, et al. Evaluation of prediction accuracy for volume of distribution in rat and human using in vitro, in vivo, PBPK and QSAR methods. J Pharm Sci. 2021;110(4):1799–823.

Article  PubMed  CAS  Google Scholar 

Shah DK, Betts AM. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn. 2012;39(1):67–86.

Article  PubMed  CAS  Google Scholar 

Bayliss MK, Bell JA, Jenner WN, Park GR, Wilson K. Utility of hepatocytes to model species differences in the metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and man. Xenobiotica. 1999;29(3):253–68.

Article  PubMed  CAS  Google Scholar 

Zamek-Gliszczynski MJ, Lee CA, Poirier A, Bentz J, Chu X, Ellens H, et al. ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans. Clin Pharmacol Ther. 2013;94(1):64–79.

Article  PubMed  CAS  Google Scholar 

Kim SJ, Lee KR, Miyauchi S, Sugiyama Y. Extrapolation of in vivo hepatic clearance from in vitro uptake clearance by suspended human hepatocytes for anionic drugs with high binding to human albumin: improvement of in vitro-to-in vivo extrapolation by considering the “Albumin-Mediated” hepatic uptake mechanism on the basis of the “Facilitated-Dissociation Model.” Drug Metab Dispos. 2019;47(2):94–103.

Article  PubMed  CAS  Google Scholar 

Li N, Badrinarayanan A, Ishida K, Li X, Roberts J, Wang S, et al. Albumin-mediated uptake improves human clearance prediction for hepatic uptake transporter substrates aiding a mechanistic in vitro-in vivo extrapolation (IVIVE) strategy in discovery research. AAPS J. 2020;23(1):1.

Article  PubMed  Google Scholar 

Bi YA, Ryu S, Tess DA, Rodrigues AD, Varma MVS. Effect of human plasma on hepatic uptake of organic anion-transporting polypeptide 1B substrates: studies using transfected cells and primary human hepatocytes. Drug Metab Dispos. 2021;49(1):72–83.

Article  PubMed  CAS  Google Scholar 

Yin M, Storelli F, Unadkat JD. Is the protein-mediated uptake of drugs by organic anion transporting polypeptides a real phenomenon or an artifact? Drug Metab Dispos. 2022;50(9):1132–41.

Article  PubMed  CAS  Google Scholar 

Li R, Barton HA, Maurer TS. Toward prospective prediction of pharmacokinetics in OATP1B1 genetic variant populations. CPT Pharmacometr Syst Pharmacol. 2014;3(12): e151.

Article  CAS  Google Scholar 

Weber C, Schmitt R, Birnboeck H, Hopfgartner G, van Marle SP, Peeters PA, et al. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects. Clin Pharmacol Ther. 1996;60(2):124–37.

Article  PubMed  CAS  Google Scholar 

Kalliokoski A, Niemi M. Impact of OATP transporters on pharmacokinetics. Br J Pharmacol. 2009;158(3):693–705.

Article  PubMed  CAS  Google Scholar 

Rodgers T, Rowland M. Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci. 2006;95(6):1238–57.

Article  PubMed  CAS  Google Scholar 

Di L, Kerns EH. Chapter 19—Pharmacokinetics. In: Di L, Kerns EH, editors. Drug-like properties. 2nd ed. Boston: Academic Press; 2016. p. 267–81.

Chapter  Google Scholar 

Watanabe T, Kusuhara H, Maeda K, Shitara Y, Sugiyama Y. Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther. 2009;328(2):652–62.

Article  PubMed  CAS  Google Scholar 

Chien HC, Zur AA, Maurer TS, Yee SW, Tolsma J, Jasper P, et al. Rapid method to determine intracellular drug concentrations in cellular uptake assays: application to metformin in organic cation transporter 1-transfected human embryonic kidney 293 cells. Drug Metab Dispos. 2016;44(3):356–64.

Article  PubMed  CAS  Google Scholar